1. Home
  2. RDHL vs OLB Comparison

RDHL vs OLB Comparison

Compare RDHL & OLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • OLB
  • Stock Information
  • Founded
  • RDHL 2009
  • OLB 1993
  • Country
  • RDHL Israel
  • OLB United States
  • Employees
  • RDHL N/A
  • OLB N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • OLB EDP Services
  • Sector
  • RDHL Health Care
  • OLB Technology
  • Exchange
  • RDHL Nasdaq
  • OLB Nasdaq
  • Market Cap
  • RDHL 3.9M
  • OLB 4.4M
  • IPO Year
  • RDHL N/A
  • OLB N/A
  • Fundamental
  • Price
  • RDHL $1.51
  • OLB $1.26
  • Analyst Decision
  • RDHL
  • OLB
  • Analyst Count
  • RDHL 0
  • OLB 0
  • Target Price
  • RDHL N/A
  • OLB N/A
  • AVG Volume (30 Days)
  • RDHL 88.5K
  • OLB 117.7K
  • Earning Date
  • RDHL 09-05-2025
  • OLB 08-19-2025
  • Dividend Yield
  • RDHL N/A
  • OLB N/A
  • EPS Growth
  • RDHL N/A
  • OLB N/A
  • EPS
  • RDHL N/A
  • OLB N/A
  • Revenue
  • RDHL $9,550,000.00
  • OLB $10,410,379.00
  • Revenue This Year
  • RDHL $381.91
  • OLB N/A
  • Revenue Next Year
  • RDHL N/A
  • OLB N/A
  • P/E Ratio
  • RDHL N/A
  • OLB N/A
  • Revenue Growth
  • RDHL 157.62
  • OLB N/A
  • 52 Week Low
  • RDHL $1.06
  • OLB $0.95
  • 52 Week High
  • RDHL $11.70
  • OLB $3.27
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 54.23
  • OLB 48.92
  • Support Level
  • RDHL $1.22
  • OLB $1.00
  • Resistance Level
  • RDHL $1.60
  • OLB $1.38
  • Average True Range (ATR)
  • RDHL 0.08
  • OLB 0.12
  • MACD
  • RDHL 0.04
  • OLB 0.04
  • Stochastic Oscillator
  • RDHL 76.32
  • OLB 65.00

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About OLB The OLB Group Inc.

The OLB Group Inc is a diversified fintech e-commerce merchant services provider and Bitcoin crypto mining enterprise. It focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. Along with its subsidiaries, the company offers a cloud-based business management platform that provides turnkey solutions for merchants to enable them to build and manage their retail businesses, whether online or at a brick-and-mortar location, payment processing solutions, payment gateway, virtual terminal with proprietary business management tools, and crowdfunding solutions. The company has two business segments; Fintech Services which generates key revenue, and the Bitcoin Mining business segment.

Share on Social Networks: